Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs

NCT05857384 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: IHL42X
DRUG: Acetazolamide 250 MG
DRUG: Dronabinol 2.5 MG

Sponsor

Incannex Healthcare Ltd